These emerging therapies , Retatrutide, represent a remarkable advancement in managing obesity and potentially other conditions . These drugs are categorized as GLP-1 pathway agonists , indicating these substances to mimic the endogenous GLP-1 peptide, enhancing insulin production and suppressing hunger . While Retatrutide each works somewhat si… Read More